Antimicrobial resistance in bacterial chronic sinusitis

American Journal of Rhinology

Volumn 12, Issue 4, 1998, Pages 243-248

  Hsu, John ^a   Lanza, Donald C ^a   Kennedy, David W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM; BACTERIUM IDENTIFICATION; CHRONIC DISEASE; CLASSIFICATION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY; SINUSITIS; STAPHYLOCOCCUS;

ADOLESCENT; ADULT; AGED; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL TYPING TECHNIQUES; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY; SINUSITIS; STAPHYLOCOCCUS;

EID: 0032118406     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065898781390055     Document Type: Article

References (38)

1. National Disease and Therapeutic Index. Plymouth Meeting, Pa: IMS Inc., pp. 963-976, 1994.
2. Kennedy DW (Ed.), Sinus disease: Guide to first - line management, From: International Conference on Sinus Disease: Terminology; Staging; Therapy. July 24-25, 1993.
3. Gwaltney JM, Scheid W Michael, Sande MA, and Sydnor A.The microbial therapy of adults with acute community-acquired sinusitis: A fifteen-year experience at the university of Virginia and review of other selected studies. J Allergy Clin Immunol 90; 3; Part 2:457-461, 1992.
4. Kennedy DW. Overview: First-line management of sinusitis: A national problem. Otolaryngol Head Neck Surg 103:5; Part 2: 847-854, 1990.
5. Böiger WE. Gram negative sinusitis: An emerging clinical entity. Am J Rhino) 8:279-284, 1994.
6. Cohen ML. Emerging problems of antimicrobial resistance. Reprint of presentation at the Infectious diseases: A focus on current concepts and emerging therapies in emergency care symposium in Dearborn, Michigan, September 1993.
7. Cohen ML. Epidemiology of drug resistance: Implications for a post-antimicrobial era. Science 257:1050-1055, 1992.
8. Neu HC.The crisis in antibiotic resistance. Science 257:10641073, 1992.
9. Poole MD. Quinolones in the pédiatrie patient. ENT J pp. 162, 1993.
10. Kennedy DW, Zinreich SJ, Rosenbaum AE, Johns ME. Functional endoscopie sinus surgery.Theory and diagnostic evaluation.Arch Otolaryngol Head Neck Surg 111:576-582, 1985.
11. Guidelines for antimicrobial therapy: 1993-1994. Antibiotic management team and the division of infectious diseases. Hospital of the University of Pennsylvania, 1994.
12. Muntz HR, Lusk RP. Bacteriology of the ethmoid bullae in children with chronic sinusitis.Arch Otolaryngol- Head Neck Surg 117:179-181, 1991.
13. Orobello PW, Park RJ, Belcher LJ,et al. Microbiology of chronic sinusitis in children.Arch Otolaryngol- Head Neck Surg 117:980-983, 1991.
14. Brook I. Bacteriological features of chronic sinusitis in children. JAMA 246:967-969, 1981.
15. Brook I. Bacteriology of chronic maxillary sinusitis in adults. Anna Otol Rhinol Laryngol 89:426-428, 1989.
16. Brook I. Anaerobic and anaerobic bacterial flora of normal maxillary sinuses.Laryngoscope 91:372-375, 1981.
17. Frederick J, Braude AI. Anaerobic infection of the paranasal sinuses.NEJM 290:135-137, 1974.
18. Su W-Y, Liu CH, Shuian-Yeng, Tsai W-F. Bacteriological study in chronic maxillary sinusitis.Laryngoscope 93:931-934, 1983.
19. Karma P, Jokipii L, Sipila P,et al. Bacteria in chronic maxillary sinusitis.Arch Otolaryngol 105:386-390, 1979.
20. Sidebottom DG. Fifteen-year experience with bloodstream isolates of coagulase-negative staphylococci neonatal intensive care.J Clin Microbiol 26:713-718, 1988.
21. Freeman J. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units.NEJM 323:301-308, 1990.
22. Patrick C. Coagulase-negative staphylococci: pathogens with increasing clinical significance.J Pediatr 116:497-507, 1990.
23. Davies AJ. Coagulase negative staphylococcus infections.Br MedJ 290:1230-1231, 1985.
24. Pfaller MA, Herwaldt LA. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci.Clin Microbiol Rev 1:281-299, 1988.
25. Klein JO. Coagulase-negative staphylococci: From harmless commensal to invasive pathogen.NEJM 323:339-340, 1990.
26. Molnàr C, Hevessy Z, Rozgonyi F, Gemmell CG. Pathogenicity and virulence of coagulase negative staphylococci in relation to adherence, hydrophobicity, and toxin production in vitro.J Clin Pathol 47:743-748, 1994.
27. Baddour LM. Virulence of coagulase-deficient mutants of staphylococcus aureus in experimental endocarditis.J Med Microbiol 41:259-263, 1994.
28. Fung-Tomc J, Kolek B, Bonner DP. Ciprofloxacin induced, low-level resistance to structurally unrelated antibiotics in pseudomonas aeruginosa and methicillin resistant staphylococcus aureus.Antimicrob Agents Chemother 37:1289-1296, 1993.
29. Koltai PJ, Maisel BO, Goldstein JC. Pseudomonas aeruginosa in chronic maxillary sinusitis.Laryngoscope 95:34-37, 1985.
30. Edelstein DR. Once-a-day therapy for sinusitis: A comparison study of cefixime and amoxacillin.Laryngoscope 103:33-41, 1993.
31. Dalhoff A.Clinical perspectives of quinolone resistance in pseudomonas aeruginosa.Antibiotics Chemother 44:221-239, 991.
32. Shalit I, Haas H, Berger SA. Susceptibility of pseudomonas aeruginosa to fluoroquinolones following four years of use in a tertiary care hospital.J Antimicrobial Chemother 30:149-152, 992.
33. Waites Ken. Multicenter in vitro comparative study of fluoroquinolones after four years of widespread clinical use.Diag Microbiol Infect Dis 18:181-189, 1994.
34. Carnefelt C, Eneroth C-M, Lunderberg C, Wretlind B. Evaluation of the antibiotic effect of treatment of maxillary sinusitis.Scandi J Infect Dis 7:259-264, 1975.
35. Dalhoff A. Quinolone resistance in pseudomonas aeruginosa and staphylococcus aureus. Development during therapy and clinical significance.Infection: 2:8111-121, 1994.
36. Wald ER. Microbiology of acute and chronic sinusitis in children.J Clin Immunol 90:45256, 1992.
37. Smith BR. National cooperative study of ciprofloxacin susceptibility in the United States.Curr Therapeutic Res 47:962-970, 1990.
38. Thornsberry C, Brown SD, Bouchillon SK,et al. Susceptibility of clinical bacterial isolates to ciprofloxacin in the United States. Inst Microbiol Res, 1993. D